Your browser doesn't support javascript.
loading
Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity.
Liang, Y; Li, Z; Liang, S; Li, Y; Yang, L; Lu, M; Gu, H F; Xia, N.
Affiliation
  • Liang Y; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li Z; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liang S; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li Y; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Yang L; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Lu M; Department of Endocrinology and Metabolism, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Gu HF; Department of Oncology-Pathology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Xia N; Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
Nutr Diabetes ; 6: e191, 2016 Jan 25.
Article in En | MEDLINE | ID: mdl-26807509

Full text: 1 Database: MEDLINE Main subject: Insulin Resistance / Adenylyl Cyclases / Diabetes Mellitus, Type 2 / Liraglutide / Hypoglycemic Agents / Liver / Obesity Limits: Animals Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Insulin Resistance / Adenylyl Cyclases / Diabetes Mellitus, Type 2 / Liraglutide / Hypoglycemic Agents / Liver / Obesity Limits: Animals Language: En Year: 2016 Type: Article